Philips and Biocompatibles team-up to advance in interventional oncology

Launch of collaboration marked with development of new treatment protocol for trans-arterial embolization in hypervascular tumors.

Photo: Philips and Biocompatibles team-up to advance in interventional oncology

Royal Philips Electronics (NYSE: PHG, AEX: PHI) and Biocompatibles, a BTG international group company, announced a collaboration to advance the use of image guidance to control the delivery of beads during the arterial embolization of hypervascularized tumors at the annual CIRSE (Cardiovascular and Interventional Radiological Society of Europe) meeting.

The first undertaking* of this new collaboration will be the development of a new treatment protocol for trans-arterial embolization – a process demonstrated to reduce the size or rate of growth of tumors. This is done by blocking the blood supply to a tumor (embolization) using an embolic material (in this case, beads). The aim of this protocol is to standardize and optimize the current approach to treatment delivery, thereby ensuring the best possible patient outcome.

The trend towards such minimally invasive treatments continues to grow in interventional oncology. This requires an integrated approach from image guidance and medical devices to provide controlled delivery of treatment that will both enable physicians to perform their procedures with more precision, and reduce discomfort for the patient.

“Personalized and less invasive treatment is the way forward in patient care,” says Louise Verheij, VP Marketing BU iXR. “As part of our strategy, Philips is committed to delivering integrated interventional solutions for image-guided minimally invasive procedures by working closely with hospitals and industry partners in different application spaces. Combining the leadership positions of Philips, in the field of advanced image guidance, and Biocompatibles, in the field of embolization beads, we strive to deliver reproducible and quantifiable results in Image Guided Interventional Oncology. This is an important step in helping advance patient care.”

“As a leader in beads for interventional oncology, we are investing in the optimization techniques used for embolization procedures in order to further improve the safety and efficacy of the procedure at a macro level,” says Mike Motion, General Manager Interventional Oncology of Biocompatibles. “Partnering with Philips will strengthen our ability to develop integrated techniques and image guidance to enhance the arterial embolization of hypervascularized tumors with beads, the ultimate objective being the advancement of interventional oncology.”

* Further to the planned protocol development, the scope of collaboration and development activities between Philips and BTG is currently being finalized, with additional announcements expected to be made in 2013
 

20.09.2012

Read all latest stories

Related articles

Photo

Going digital

How digital pathology is shaping the future of precision medicine

In recent years, technological and regulatory advances have made digital pathology a viable alternative to the conventional microscope. The obtention of a digital replica of the traditional glass…

Photo

Solution for pediatric assessment

Ultrasound: A gentler approach to imaging children

Royal Philips announced the ultimate ultrasound solution for pediatric assessment, the latest addition for its Philips Ultrasound System (EPIQ Elite). The new ultrasound solution provides clinicians…

Photo

Digital PET imaging

Digital Photon Counting improves diagnostic accuracy

Built as the first commercially available scanner to deliver truly digital PET, the Vereos PET/CT, from Philips, offers revolutionary Digital Photon Counting technology. The science behind this…

Related products

Canon – Alphenix Core

Single Plane

Canon – Alphenix Core

Canon Medical Systems Europe B.V.
Canon – Alphenix Core+

Single Plane

Canon – Alphenix Core+

Canon Medical Systems Europe B.V.
Canon – Alphenix Core+

Single Plane

Canon – Alphenix Core+

Canon Medical Systems Europe B.V.
Canon – Alphenix Hybrid

Single Plane

Canon – Alphenix Hybrid

Canon Medical Systems Europe B.V.
Canon – Alphenix Hybrid+

Single Plane

Canon – Alphenix Hybrid+

Canon Medical Systems Europe B.V.
Canon – Alphenix Sky

Single Plane

Canon – Alphenix Sky

Canon Medical Systems Europe B.V.